Diagnostic and Biotech

NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

  • THE3206907
  • 205 Pages
  • January 2019
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.

The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.

The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period

Some of the major primary and secondary sources included in the report NGS based RNA seq market are National Institutes of Health, National Science Foundation, Canada foundation for innovation, African Society of Human Genetics, Department of Biotechnology, Dubai Health Authority, Human Heredity and Health in Africa, French National Cancer Institute, Japan Science and Technology Agency, Trinity Translational Medicine Institute and others.

TABLE OF CONTENTS

1. INTRODUCTION 29

1.1 SCOPE OF THE STUDY 29

1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29

2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31

3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34

3.1 OVERVIEW 34

3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35

3.1.2 Global NGS Based RNA Seq Market - By Technology 36

3.1.3 Global NGS Based RNA Seq Market - By Application 36

3.1.4 Global NGS Based RNA Seq Market - By End User 36

3.1.5 Global NGS Based RNA Seq Market - By Geography 36

3.2 PEST ANALYSIS 37

3.2.1 North America PEST Analysis 37

3.2.2 Europe PEST Analysis 39

3.2.3 Asia Pacific PEST Analysis 41

3.2.4 Middle East & Africa PEST Analysis 43

3.2.5 South & Central America PEST Analysis 45

4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47

4.1 KEY MARKET DRIVERS 47

4.1.1 Reduced Cost of Genome Sequencing 47

4.1.2 Advancements in Sequencing Technology 47

4.1.3 Next Generation Sequencing for Cancer 48

4.2 KEY MARKET RESTRAINTS 48

4.2.1 Risks Related to Genetic Data 48

4.2.2 High Cost of NGS Instruments 49

4.3 KEY MARKET OPPORTUNITIES 49

4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49

4.3.2 Different Programs for RNA Sequencing 50

4.4 FUTURE TRENDS 50

4.4.1 Barcode Scanning for Long Reads Sequences 50

4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51

5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52

5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52

5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53

5.3 MARKET POSITIONING 54

5.4 PERFORMANCE OF KEY PLAYERS 54

5.4.1 Illumina, Inc. 54

5.4.2 Thermo Fisher Scientific Inc. 55

5.5 EXPERT OPINIONS 55

6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56

6.1 OVERVIEW 56

6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56

6.3 SAMPLE PREPARATION MARKET 57

6.3.1 Overview 57

6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57

6.3.3 Method Market 58

6.3.3.1 Overview 58

6.3.3.2 Manual Method Market 58

6.3.3.2.1 Overview 58

6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59

6.3.3.3 Automated Method Market 60

6.3.3.3.1 Overview 60

6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60

6.3.4 Workflow Step Market 61

6.3.4.1 Overview 61

6.3.4.2 Library Preparation & Target Enrichment Market 61

6.3.4.2.1 Overview 61

6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62

6.3.4.3 Fragmentation, End Repair & Size Selection Market 63

6.3.4.3.1 Overview 63

6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63

6.3.4.4 Quality Control Market 64

6.3.4.4.1 Overview 64

6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64

6.4 SEQUENCING SERVICES MARKET 65

6.4.1 Overview 65

6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66

6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67

6.5.1 Overview 67

6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68

6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69

6.6.1 Overview 69

6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69

7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70

7.1 OVERVIEW 70

7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70

7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71

7.3.1 Overview 71

7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71

7.4 NANOPORE SEQUENCING MARKET 72

7.4.1 Overview 72

7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72

7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73

7.5.1 Overview 73

7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73

7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74

7.6.1 Overview 74

7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74

8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75

8.1 OVERVIEW 75

8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75

8.3 DIAGNOSTICS MARKET 76

8.3.1 Overview 76

8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76

8.4 DRUG DISCOVERY MARKET 77

8.4.1 Overview 77

8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77

8.5 PRECISION MEDICINE MARKET 78

8.5.1 Overview 78

8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78

8.6 OTHER APPLICATIONS MARKET 79

8.6.1 Overview 79

8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79

9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80

9.1 OVERVIEW 80

9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80

9.3 HOSPITALS & CLINICS MARKET 81

9.3.1 Overview 81

9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81

9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82

9.4.1 Overview 82

9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82

9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83

9.5.1 Overview 83

9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83

9.6 OTHER END USERS MARKET 84

9.6.1 Overview 84

9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84

10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85

10.1 OVERVIEW 85

10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86

10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86

10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87

10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87

10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88

10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88

10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89

10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89

10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90

10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90

10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91

10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91

10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91

10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92

10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92

10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93

10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94

10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94

10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95

10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95

10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95

10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96

10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96

10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97

10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98

10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98

10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99

10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99

10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99

10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100

10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100

10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101

11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102

11.1 OVERVIEW 102

11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103

11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103

11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104

11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104

11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104

11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105

11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105

11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106

11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107

11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108

11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108

11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109

11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109

11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109

11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110

11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110

11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111

11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111

11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112

11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112

11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112

11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113

11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113

11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114

11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115

11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115

11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116

11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116

11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116

11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117

11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117

11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118

12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119

12.1 OVERVIEW 119

12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120

12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120

12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121

12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121

12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121

12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122

12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122

12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123

12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124

12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125

12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125

12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126

12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126

12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126

12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127

12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127

12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128

12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129

12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129

12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130

12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130

12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130

12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131

12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131

12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132

12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132

12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133

12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133

12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133

12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134

12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134

12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135

13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136

13.1 OVERVIEW 136

13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137

13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137

13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138

13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138

13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139

13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139

13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140

13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140

13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141

13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141

13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142

13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142

13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142

13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143

13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143

13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144

13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145

13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145

13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146

13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146

13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146

13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147

13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147

13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148

13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149

13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149

13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150

13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150

13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151

13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151

13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151

13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152

14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153

14.1 OVERVIEW 153

14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154

14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154

14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155

14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155

14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156

14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156

14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157

14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157

14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158

14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158

14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159

14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159

14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159

14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160

14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160

14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161

15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162

15.1 OVERVIEW 162

15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162

15.3 ORGANIC DEVELOPMENTS 162

15.3.1 Overview 162

15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163

15.5 PRODUCT & SERVICE LAUNCH 163

15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163

15.6 PRODUCT APPROVAL 164

15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164

15.7 OTHERS 164

15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164

15.8 INORGANIC DEVELOPMENTS 165

15.8.1 Overview 165

15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165

15.10 PARTNERSHIPS 166

15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166

15.11 COLLABORATIONS 167

15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167

15.12 EXPANSION 168

15.12.1 The NGS-based RNA-seq Market By Expansion 168

15.13 ACQUISITIONS 169

15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169

15.14 AGREEMENTS 169

15.14.1 The NGS-based RNA-seq Market By Agreements 169

16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170

16.1 ILLUMINA, INC. 170

16.1.1 Key Facts 170

16.1.2 Business Description 170

16.1.3 Financial Overview 171

16.1.4 Product Portfolio 171

16.1.5 Swot Analysis 172

16.1.6 Key Developments 172

16.2 THERMO FISHER SCIENTIFIC INC. 174

16.2.1 Key Facts 174

16.2.2 Business Description 174

16.2.3 Financial Overview 175

16.2.4 Product Portfolio 175

16.2.5 SWOT Analysis 176

16.2.6 Key Developments 176

16.3 PERKINELMER, INC. 177

16.3.1 Key Facts 177

16.3.2 Business Description 177

16.3.3 Financial Overview 178

16.3.4 Product Portfolio 178

16.3.5 SWOT Analysis 179

16.3.6 Key Developments 179

16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180

16.4.1 Key Facts 180

16.4.2 Business Description 180

16.4.3 Financial Information 180

16.4.4 Product Portfolio 181

16.4.5 SWOT Analysis 181

16.4.6 Key Developments 181

16.5 F. HOFFMANN-LA ROCHE LTD 182

16.5.1 Key Facts 182

16.5.2 Business Description 182

16.5.3 Financial Information 183

16.5.4 Product Portfolio 183

16.5.5 SWOT Analysis 184

16.5.6 Key Developments 184

16.6 QIAGEN 185

16.6.1 Key Facts 185

16.6.2 Business Description 185

16.6.3 Financial Information 186

16.6.4 Product Portfolio 186

16.6.5 SWOT Analysis 187

16.6.6 Key Developments 188

16.7 AGILENT TECHNOLOGIES 190

16.7.1 Key Facts 190

16.7.2 Business Description 190

16.7.3 Financial Overview 191

16.7.4 Product Portfolio 191

16.7.5 SWOT Analysis 192

16.7.6 Key Developments 192

16.8 BGI 193

16.8.1 Key Facts 193

16.8.2 Business Description 193

16.8.3 Financial Overview 193

16.8.4 Product Portfolio 193

16.8.5 SWOT Analysis 194

16.8.6 Key Developments 194

16.9 OXFORD NANOPORE TECHNOLOGIES 195

16.9.1 Key Facts 195

16.9.2 Business Description 195

16.9.3 Financial Overview 195

16.9.4 Product Portfolio 195

16.9.5 SWOT ANALYSIS 196

16.9.6 Key Developments 196

16.10 EUROFINS SCIENTIFIC 197

16.10.1 Key Facts 197

16.10.2 Business Description 197

16.10.3 Financial Overview 197

16.10.4 Product Portfolio 198

16.10.5 SWOT Analysis 198

16.10.6 Key Developments 198

17. APPENDIX 199

17.1 ABOUT THE INSIGHT PARTNERS 199

17.2 GLOSSARY OF TERMS 200

17.3 METHODOLOGY 202

17.3.1 Coverage 203

17.3.2 Secondary Research 203

17.3.3 Primary Research 204

LIST OF TABLES

TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86

TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87

TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87

TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88

TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88

TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89

TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91

TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91

TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91

TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92

TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92

TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93

TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95

TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95

TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95

TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96

TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96

TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97

TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99

TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99

TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99

TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100

TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100

TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101

TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103

TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104

TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104

TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104

TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105

TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105

TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108

TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109

TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109

TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109

TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110

TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110

TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112

TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112

TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112

TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113

TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113

TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114

TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116

TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116

TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116

TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117

TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117

TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118

TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120

TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121

TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121

TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121

TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122

TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122

TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125

TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126

TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126

TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126

TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127

TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127

TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129

TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130

TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130

TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130

TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131

TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131

TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133

TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133

TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (U

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370